Table of Content

1 Human Growth Hormone Deficiency (Ghd) Drug Market Overview
1.1 Product Overview and Scope of Human Growth Hormone Deficiency (Ghd) Drug
1.2 Human Growth Hormone Deficiency (Ghd) Drug Segment by Type
1.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Value Comparison by Type (2024-2034)
1.2.2 TransCon-hGH
1.2.3 Somapacitan
1.2.4 Somavaratan
1.2.5 Others
1.3 Human Growth Hormone Deficiency (Ghd) Drug Segment by Application
1.3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Value by Application: (2024-2034)
1.3.2 Children
1.3.3 Adults
1.4 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size Estimates and Forecasts
1.4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue 2018-2029
1.4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales 2018-2029
1.4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Human Growth Hormone Deficiency (Ghd) Drug Market Competition by Manufacturers
2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Average Price by Manufacturers (2018-2024)
2.4 Global Human Growth Hormone Deficiency (Ghd) Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Product Type & Application
2.7 Human Growth Hormone Deficiency (Ghd) Drug Market Competitive Situation and Trends
2.7.1 Human Growth Hormone Deficiency (Ghd) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Growth Hormone Deficiency (Ghd) Drug Players Market Share by Revenue
2.7.3 Global Human Growth Hormone Deficiency (Ghd) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Growth Hormone Deficiency (Ghd) Drug Retrospective Market Scenario by Region
3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2018-2029
3.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2018-2024
3.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region: 2024-2029
3.3 Global Human Growth Hormone Deficiency (Ghd) Drug Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2018-2029
3.3.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2018-2024
3.3.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2024-2029
3.4 North America Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
3.4.1 North America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2029)
3.4.3 North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
3.5.1 Europe Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2029)
3.5.3 Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
3.7.1 Latin America Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2029)
3.7.3 Latin America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2018-2029)
4.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2018-2024)
4.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Type (2024-2029)
4.1.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2018-2029)
4.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2018-2029)
4.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2018-2024)
4.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Type (2024-2029)
4.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2018-2029)
4.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2018-2029)
5.1.1 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2018-2024)
5.1.2 Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Application (2024-2029)
5.1.3 Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2018-2029)
5.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2018-2029)
5.2.1 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2018-2024)
5.2.2 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Application (2024-2029)
5.2.3 Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2018-2029)
5.3 Global Human Growth Hormone Deficiency (Ghd) Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AnkeBio Co. Ltd
6.1.1 AnkeBio Co. Ltd Corporation Information
6.1.2 AnkeBio Co. Ltd Description and Business Overview
6.1.3 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.1.5 AnkeBio Co. Ltd Recent Developments/Updates
6.2 Eli Lilly and Company
6.2.1 Eli Lilly and Company Corporation Information
6.2.2 Eli Lilly and Company Description and Business Overview
6.2.3 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.2.5 Eli Lilly and Company Recent Developments/Updates
6.3 EMD Serono Inc.
6.3.1 EMD Serono Inc. Corporation Information
6.3.2 EMD Serono Inc. Description and Business Overview
6.3.3 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.3.5 EMD Serono Inc. Recent Developments/Updates
6.4 Ferring Pharmaceuticals
6.4.1 Ferring Pharmaceuticals Corporation Information
6.4.2 Ferring Pharmaceuticals Description and Business Overview
6.4.3 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.4.5 Ferring Pharmaceuticals Recent Developments/Updates
6.5 Genentech, Inc (Roche)
6.5.1 Genentech, Inc (Roche) Corporation Information
6.5.2 Genentech, Inc (Roche) Description and Business Overview
6.5.3 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.5.5 Genentech, Inc (Roche) Recent Developments/Updates
6.6 GeneScience Pharmaceuticals Co. Ltd
6.6.1 GeneScience Pharmaceuticals Co. Ltd Corporation Information
6.6.2 GeneScience Pharmaceuticals Co. Ltd Description and Business Overview
6.6.3 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.6.5 GeneScience Pharmaceuticals Co. Ltd Recent Developments/Updates
6.7 Ipsen S.A.
6.6.1 Ipsen S.A. Corporation Information
6.6.2 Ipsen S.A. Description and Business Overview
6.6.3 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.7.5 Ipsen S.A. Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Merck KGaA
6.9.1 Merck KGaA Corporation Information
6.9.2 Merck KGaA Description and Business Overview
6.9.3 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.9.5 Merck KGaA Recent Developments/Updates
6.10 Sandoz International GmbH (Novartis AG)
6.10.1 Sandoz International GmbH (Novartis AG) Corporation Information
6.10.2 Sandoz International GmbH (Novartis AG) Description and Business Overview
6.10.3 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.10.5 Sandoz International GmbH (Novartis AG) Recent Developments/Updates
6.11 Strongbridge Biopharma
6.11.1 Strongbridge Biopharma Corporation Information
6.11.2 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.11.3 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.11.5 Strongbridge Biopharma Recent Developments/Updates
6.12 Teva Pharmaceutical Industries, Ltd
6.12.1 Teva Pharmaceutical Industries, Ltd Corporation Information
6.12.2 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.12.3 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.12.5 Teva Pharmaceutical Industries, Ltd Recent Developments/Updates
6.13 Novo Nordisk A/S
6.13.1 Novo Nordisk A/S Corporation Information
6.13.2 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.13.3 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.13.5 Novo Nordisk A/S Recent Developments/Updates
6.14 Pfizer Inc
6.14.1 Pfizer Inc Corporation Information
6.14.2 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.14.3 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.14.5 Pfizer Inc Recent Developments/Updates
6.15 Opko Health, Inc.
6.15.1 Opko Health, Inc. Corporation Information
6.15.2 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.15.3 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.15.5 Opko Health, Inc. Recent Developments/Updates
6.16 Ascendis Pharma A/S
6.16.1 Ascendis Pharma A/S Corporation Information
6.16.2 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.16.3 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.16.5 Ascendis Pharma A/S Recent Developments/Updates
6.17 Versartis Inc.
6.17.1 Versartis Inc. Corporation Information
6.17.2 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Description and Business Overview
6.17.3 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product Portfolio
6.17.5 Versartis Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Growth Hormone Deficiency (Ghd) Drug Industry Chain Analysis
7.2 Human Growth Hormone Deficiency (Ghd) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Growth Hormone Deficiency (Ghd) Drug Production Mode & Process
7.4 Human Growth Hormone Deficiency (Ghd) Drug Sales and Marketing
7.4.1 Human Growth Hormone Deficiency (Ghd) Drug Sales Channels
7.4.2 Human Growth Hormone Deficiency (Ghd) Drug Distributors
7.5 Human Growth Hormone Deficiency (Ghd) Drug Customers
8 Human Growth Hormone Deficiency (Ghd) Drug Market Dynamics
8.1 Human Growth Hormone Deficiency (Ghd) Drug Industry Trends
8.2 Human Growth Hormone Deficiency (Ghd) Drug Market Drivers
8.3 Human Growth Hormone Deficiency (Ghd) Drug Market Challenges
8.4 Human Growth Hormone Deficiency (Ghd) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Growth Hormone Deficiency (Ghd) Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Growth Hormone Deficiency (Ghd) Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Growth Hormone Deficiency (Ghd) Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Human Growth Hormone Deficiency (Ghd) Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Human Growth Hormone Deficiency (Ghd) Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Product Type & Application
Table 12. Global Key Manufacturers of Human Growth Hormone Deficiency (Ghd) Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Growth Hormone Deficiency (Ghd) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Growth Hormone Deficiency (Ghd) Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2018-2024)
Table 19. Global Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2024-2029)
Table 21. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2018-2024)
Table 53. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Type (2024-2029)
Table 54. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2018-2024)
Table 63. Global Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Application (2024-2029)
Table 64. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Application (2024-2029)
Table 70. AnkeBio Co. Ltd Corporation Information
Table 71. AnkeBio Co. Ltd Description and Business Overview
Table 72. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. AnkeBio Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product
Table 74. AnkeBio Co. Ltd Recent Developments/Updates
Table 75. Eli Lilly and Company Corporation Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Eli Lilly and Company Human Growth Hormone Deficiency (Ghd) Drug Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. EMD Serono Inc. Corporation Information
Table 81. EMD Serono Inc. Description and Business Overview
Table 82. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. EMD Serono Inc. Human Growth Hormone Deficiency (Ghd) Drug Product
Table 84. EMD Serono Inc. Recent Developments/Updates
Table 85. Ferring Pharmaceuticals Corporation Information
Table 86. Ferring Pharmaceuticals Description and Business Overview
Table 87. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Ferring Pharmaceuticals Human Growth Hormone Deficiency (Ghd) Drug Product
Table 89. Ferring Pharmaceuticals Recent Developments/Updates
Table 90. Genentech, Inc (Roche) Corporation Information
Table 91. Genentech, Inc (Roche) Description and Business Overview
Table 92. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Genentech, Inc (Roche) Human Growth Hormone Deficiency (Ghd) Drug Product
Table 94. Genentech, Inc (Roche) Recent Developments/Updates
Table 95. GeneScience Pharmaceuticals Co. Ltd Corporation Information
Table 96. GeneScience Pharmaceuticals Co. Ltd Description and Business Overview
Table 97. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. GeneScience Pharmaceuticals Co. Ltd Human Growth Hormone Deficiency (Ghd) Drug Product
Table 99. GeneScience Pharmaceuticals Co. Ltd Recent Developments/Updates
Table 100. Ipsen S.A. Corporation Information
Table 101. Ipsen S.A. Description and Business Overview
Table 102. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Ipsen S.A. Human Growth Hormone Deficiency (Ghd) Drug Product
Table 104. Ipsen S.A. Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. LG Life Sciences Human Growth Hormone Deficiency (Ghd) Drug Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Merck KGaA Corporation Information
Table 111. Merck KGaA Description and Business Overview
Table 112. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Merck KGaA Human Growth Hormone Deficiency (Ghd) Drug Product
Table 114. Merck KGaA Recent Developments/Updates
Table 115. Sandoz International GmbH (Novartis AG) Corporation Information
Table 116. Sandoz International GmbH (Novartis AG) Description and Business Overview
Table 117. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Sandoz International GmbH (Novartis AG) Human Growth Hormone Deficiency (Ghd) Drug Product
Table 119. Sandoz International GmbH (Novartis AG) Recent Developments/Updates
Table 120. Strongbridge Biopharma Corporation Information
Table 121. Strongbridge Biopharma Description and Business Overview
Table 122. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Strongbridge Biopharma Human Growth Hormone Deficiency (Ghd) Drug Product
Table 124. Strongbridge Biopharma Recent Developments/Updates
Table 125. Teva Pharmaceutical Industries, Ltd Corporation Information
Table 126. Teva Pharmaceutical Industries, Ltd Description and Business Overview
Table 127. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Teva Pharmaceutical Industries, Ltd Human Growth Hormone Deficiency (Ghd) Drug Product
Table 129. Teva Pharmaceutical Industries, Ltd Recent Developments/Updates
Table 130. Novo Nordisk A/S Corporation Information
Table 131. Novo Nordisk A/S Description and Business Overview
Table 132. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Novo Nordisk A/S Human Growth Hormone Deficiency (Ghd) Drug Product
Table 134. Novo Nordisk A/S Recent Developments/Updates
Table 135. Pfizer Inc Corporation Information
Table 136. Pfizer Inc Description and Business Overview
Table 137. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Pfizer Inc Human Growth Hormone Deficiency (Ghd) Drug Product
Table 139. Pfizer Inc Recent Developments/Updates
Table 140. Opko Health, Inc. Corporation Information
Table 141. Opko Health, Inc. Description and Business Overview
Table 142. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Opko Health, Inc. Human Growth Hormone Deficiency (Ghd) Drug Product
Table 144. Opko Health, Inc. Recent Developments/Updates
Table 145. Ascendis Pharma A/S Corporation Information
Table 146. Ascendis Pharma A/S Description and Business Overview
Table 147. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Ascendis Pharma A/S Human Growth Hormone Deficiency (Ghd) Drug Product
Table 149. Ascendis Pharma A/S Recent Developments/Updates
Table 150. Versartis Inc. Corporation Information
Table 151. Versartis Inc. Description and Business Overview
Table 152. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Versartis Inc. Human Growth Hormone Deficiency (Ghd) Drug Product
Table 154. Versartis Inc. Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Growth Hormone Deficiency (Ghd) Drug Distributors List
Table 158. Human Growth Hormone Deficiency (Ghd) Drug Customers List
Table 159. Human Growth Hormone Deficiency (Ghd) Drug Market Trends
Table 160. Human Growth Hormone Deficiency (Ghd) Drug Market Drivers
Table 161. Human Growth Hormone Deficiency (Ghd) Drug Market Challenges
Table 162. Human Growth Hormone Deficiency (Ghd) Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Growth Hormone Deficiency (Ghd) Drug
Figure 2. Global Human Growth Hormone Deficiency (Ghd) Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Growth Hormone Deficiency (Ghd) Drug Market Share by Type in 2022 & 2029
Figure 4. TransCon-hGH Product Picture
Figure 5. Somapacitan Product Picture
Figure 6. Somavaratan Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Growth Hormone Deficiency (Ghd) Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Human Growth Hormone Deficiency (Ghd) Drug Market Share by Application in 2022 & 2029
Figure 10. Children
Figure 11. Adults
Figure 12. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size (2018-2029) & (US$ Million)
Figure 14. Global Human Growth Hormone Deficiency (Ghd) Drug Sales (2018-2029) & (K Units)
Figure 15. Global Human Growth Hormone Deficiency (Ghd) Drug Average Price (USD/Unit) & (2018-2029)
Figure 16. Human Growth Hormone Deficiency (Ghd) Drug Report Years Considered
Figure 17. Human Growth Hormone Deficiency (Ghd) Drug Sales Share by Manufacturers in 2022
Figure 18. Global Human Growth Hormone Deficiency (Ghd) Drug Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Human Growth Hormone Deficiency (Ghd) Drug Players: Market Share by Revenue in 2022
Figure 20. Human Growth Hormone Deficiency (Ghd) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Human Growth Hormone Deficiency (Ghd) Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2018-2029)
Figure 23. North America Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Country (2018-2029)
Figure 24. United States Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2018-2029)
Figure 27. Europe Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Country (2018-2029)
Figure 28. Germany Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Region (2018-2029)
Figure 35. China Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2018-2029)
Figure 45. Latin America Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Human Growth Hormone Deficiency (Ghd) Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Human Growth Hormone Deficiency (Ghd) Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Human Growth Hormone Deficiency (Ghd) Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of Human Growth Hormone Deficiency (Ghd) Drug by Type (2018-2029)
Figure 56. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Human Growth Hormone Deficiency (Ghd) Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of Human Growth Hormone Deficiency (Ghd) Drug by Application (2018-2029)
Figure 59. Global Human Growth Hormone Deficiency (Ghd) Drug Price (USD/Unit) by Application (2018-2029)
Figure 60. Human Growth Hormone Deficiency (Ghd) Drug Value Chain
Figure 61. Human Growth Hormone Deficiency (Ghd) Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed